Principles of Adolescent Substance Use Disorder Treatment PDF
Principles of Adolescent Substance Use Disorder Treatment PDF
Principles of Adolescent Substance Use Disorder Treatment PDF
Tina Burrell, M.A., Washington State Department of Social and Health Services
Kenneth J. Martz, Psy.D., CAS, Pennsylvania Department of Drug and Alcohol Programs
Kathy Paxton, M.S., West Virginia Bureau for Behavioral Health and Health Facilities
I. INTRODUCTION ................................................................................................................................................2
FAMILY-BASED APPROACHES........................................................................................................................25
Brief Strategic Family Therapy (BSFT).........................................................................................................25
Family Behavior Therapy (FBT)....................................................................................................................25
Functional Family Therapy (FFT)..................................................................................................................26
Multidimensional Family Therapy (MDFT)....................................................................................................26
Multisystemic Therapy (MST).......................................................................................................................26
ADDICTION MEDICATIONS.............................................................................................................................26
Opioid Use Disorders....................................................................................................................................27
Alcohol Use Disorders..................................................................................................................................27
Nicotine Use Disorders.................................................................................................................................28
RECOVERY SUPPORT SERVICES..................................................................................................................28
Assertive Continuing Care (ACC).................................................................................................................28
Mutual Help Groups......................................................................................................................................29
Peer Recovery Support Services..................................................................................................................29
Recovery High Schools.................................................................................................................................29
REFERENCES.........................................................................................................................................................32
From the Director
Since its first edition in 1999, NIDA’s Principles of Drug Addiction Treatment
has been a widely used resource for health care providers, families, and others
needing information on addiction and treatment for people of all ages. But recent
research has greatly advanced our understanding of the particular treatment
needs of adolescents, which are often different from those of adults. I thus am
very pleased to present this new guide, Principles of Adolescent Substance Use
Disorder Treatment, focused exclusively on the unique realities of adolescent
substance use—which includes abuse of illicit and prescription drugs, alcohol,
and tobacco—and the special treatment needs for people aged 12 to 17.
The adolescent years are a key window for both substance use and the
development of substance use disorders. Brain systems governing emotion and
reward-seeking are fully developed by this time, but circuits governing judgment
and self-inhibition are still maturing, causing teenagers to act on impulse, seek new sensations, and be
easily swayed by their peers—all of which may draw them to take risks such as trying drugs of abuse.
What is more, because critical neural circuits are still actively forming, teens’ brains are particularly
susceptible to being modified by those substances in a lasting way—making the development of a
substance use disorder much more likely.
Addiction is not the only danger. Abusing drugs during adolescence can interfere with meeting crucial
social and developmental milestones and also compromise cognitive development. For example, heavy
marijuana use in the teen years may cause a loss of several IQ points that are not regained even if users
later quit in adulthood. Unfortunately, that drug’s popularity among teens is growing—possibly due in part
to legalization advocates touting marijuana as a “safe” drug. Nor do most young people appreciate the
grave safety risks posed by abuse of other substances like prescription opioids and stimulants or newly
popular synthetic cannabinoids (“Spice”)—and even scientists still do not know much about how abusing
these drugs may affect the developing brain.
These unknowns only add to the urgency of identifying and intervening in substance use as early as
possible. Unfortunately, this urgency is matched by the difficulty of reaching adolescents who need help.
Only 10 percent of adolescents who need treatment for a substance use disorder actually get treatment.
Most teens with drug problems don’t want or think they need help, and parents are frequently blind to
indications their teenage kids may be using drugs—or they may dismiss drug use as just a normal part of
growing up.
Historically the focus with adolescents has tended to be on steering young people clear of drugs
before problems arise. But the reality is that different interventions are needed for adolescents at
different places along the substance use spectrum, and some require treatment, not just prevention.
Fortunately, scientific research has now established the efficacy of a number of treatment approaches
that can address substance use during the teen years. This guide describes those approaches, as well
as presents a set of guiding principles and frequently asked questions about substance abuse and
treatment in this age group. I hope this guide will be of great use to parents, health care providers, and
treatment specialists as they strive to help adolescents with substance use problems get the help they
need.
* In this guide, the terms drugs and substances are used interchangeably to refer to tobacco, alcohol, illegal drugs, and prescription medications used
for nonmedical reasons.
‡ Specifying the period of adolescence is complicated because it may be defined by different variables, and policymakers and researchers may
disagree on the exact age boundaries. For purposes of this guide, adolescents are considered to be people between the ages of 12 and 17.
* For purposes of this guide, the term addiction refers to compulsive drug seeking and use that persists even in the face of devastating consequences;
it may be regarded as equivalent to a severe substance use disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5, 2013). The spectrum of substance use disorders in the DSM-5 includes the criteria for the DSM-4 diagnostic categories of abuse and
dependence.
18 – 25
70
Percent of those who received past-year treatment 26+
66.5
60
50
65.5
57.2
40
38.7
46.3
30
42.9
33.1
42.6
20
17.1
18.3
6.7
10
12.6
4.6
12.4
11.7
11.1
3.3
3.0
9.9
8.7
0 8.6
Alcohol Marijuana Prescription Cocaine Heroin Hallucinogens Inhalants
Drugs
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2013.
to stress and seek relief from it throughout age 13 or younger develop a substance use
life; this greatly increases the likelihood of disorder at some time in their lives.9 Tobacco,
subsequent drug abuse and of starting drug use alcohol, and marijuana are the first addictive
early.5 In fact, certain traits that put a person substances most people try. Data collected
at risk for drug use, such as being impulsive in 2012 found that nearly 13 percent of those
or aggressive, manifest well before the first with a substance use disorder began using
episode of drug use and may be addressed marijuana by the time they were 14.10
by prevention interventions during childhood.6
By the same token, a range of factors, such When substance use disorders occur in
as parenting that is nurturing or a healthy adolescence, they affect key developmental
school environment, may encourage healthy and social transitions, and they can interfere
development and thereby lessen the risk of later with normal brain maturation. These potentially
drug use. lifelong consequences make addressing
adolescent drug use an urgent matter. Chronic
Drug use at an early age is an important marijuana use in adolescence, for example, has
predictor of development of a substance use been shown to lead to a loss of IQ that is not
disorder later. The majority of those who have recovered even if the individual quits using in
a substance use disorder started using before adulthood.11 Impaired memory or thinking ability
age 18 and developed their disorder by age 20.7 and other problems caused by drug use can
The likelihood of developing a substance use derail a young person’s social and educational
disorder is greatest for those who begin use in development and hold him or her back in life.
their early teens. For example, 15.2 percent of
people who start drinking by age 14 eventually The serious health risks of drugs compound
develop alcohol abuse or dependence (as the need to get an adolescent who is abusing
compared to just 2.1 percent of those who wait drugs into treatment as quickly as possible.
until they are 21 or older),8 and 25 percent of Also, adolescents who are abusing drugs are
those who begin abusing prescription drugs at likely to have other issues such as mental health
200
184
150
100
50 63
46 43
28 18
0 Juvenile Self or Community Schools Treatment Other
Justice Others Organizations Providers Health
System Care
Professionals
Source: 2008 SAMHSA Treatment Episode Data Set (TEDS)
abuse treatment, follow-up care and recovery monitoring by the adolescent, parents, and
support (e.g., mutual-help groups like 12-step teachers, as well as follow-up by treatment
programs) may be important for helping teens providers. Although recovery support programs
stay off drugs and improving their quality of life. are not a substitute for formal evidence-based
treatment, they may help some adolescents
When substance use disorders are identified maintain a positive and productive drug-free
and treated in adolescence—especially if they lifestyle that promotes meaningful and beneficial
are mild or moderate—they frequently give relationships and connections to family, peers,
way to abstinence from drugs with no further and the community both during treatment and
problems. Relapse is a possibility, however, as after treatment ends. Whatever services or
it is with other chronic diseases like diabetes programs are used, an adolescent’s path to
or asthma. Relapse should not be seen as a recovery will be strengthened by support from
sign that treatment failed but as an occasion family members, non-drug-using peers, the
to engage in additional or different treatment. school, and others in his or her life.
Averting and detecting relapse involves
* “Treatment providers” in this chart refers to “alcohol/drug abuse care providers.” Treatment providers can and do refer people to treatment if, for
example, a person is transferring from one level of treatment to another and the original facility does not provide the level of treatment that the person
needs, or if a person changes facilities for some other reason. “Other health care professionals” refers to physicians, psychiatrists, or other licensed
health care professionals or general hospitals, psychiatric hospitals, mental health programs, or nursing homes.
Marijuana
related disorders, and physical pain. Using 40
drugs may be an attempt to lessen these
feelings of distress. Stress especially plays
a significant role in starting and continuing 35
drug use as well as returning to drug use ■ Illegal Drugs
36.4
Percent of High School Seniors Using in the Past Year
■ Prescription or OTC Drugs
(relapsing) for those recovering from an
addiction.
30
• To do better: Ours is a very competitive
society, in which the pressure to perform
athletically and academically can be
25
intense. Some adolescents may turn to
certain drugs like illegal or prescription
stimulants because they think those
substances will enhance or improve their 20
Prescription Painkillers*
performance.
Synthetic Marijuana
10
Sedatives
adolescents? 5
8.7
7.9
7.1
4.8
4.5
4.6
4.0
3.4
*The top drugs used in this category are Vicodin (5.3%) and OxyContin (3.6%)
tend to favor inhalant substances (such as Source: Monitoring the Future National Results on Adolescent
breathing the fumes of household cleaners, Drug Use: Summary of Key Findings, 2013.
* The treatments listed in this book are not intended to be a comprehensive list of efficacious evidence-based treatment approaches for adolescents.
NIDA continues supporting research developing new approaches to address adolescent drug abuse.
ADDICTION MEDICATIONS
Undertreating a substance use Several medications have been found to
disorder will increase the risk of be effective in treating addiction to opioids,
relapse. alcohol, or nicotine in adults, although none of
these medications have been approved by the
FDA to treat adolescents. In most cases, only
preliminary evidence exists for the effectiveness
and safety of these medications in people
under 18, and there is no evidence on the
neurobiological impact of these medications
* According to the FDA label, “SUBOXONE and SUBUTEX are not recommended for use in pediatric patients. The safety and effectiveness of
SUBOXONE and SUBUTEX in patients below the age of 16 have not been established.”
‡ Medication-assisted therapies are rarely used to treat adolescent alcohol use disorders.
2. Sussman, S.; Skara, S.; and Ames, S.L. Substance abuse among adolescents. Substance Use & Misuse 43(12–13):1802–1828,
2008.
3. Robertson, E.B.; David, S.L.; and Rao, S.A. Preventing Drug Use among Children and Adolescents: A Research-Based Guide for
Parents, Educators, and Community Leaders, 2nd ed. NIH Pub. No. 04-4212(A). Bethesda, MD: National Institute on Drug Abuse,
2003. Available at: http://www.drugabuse.gov/pdf/prevention/RedBook.pdf
4. Andersen, S.L.; and Teicher, M.H. Desperately driven and no brakes: Developmental stress exposure and subsequent risk for
substance abuse. Neuroscience & Biobehavioral Reviews 33(4):516–524, 2009.
5. Andersen, S.L.; and Teicher, M.H. Desperately driven and no brakes: Developmental stress exposure and subsequent risk for
substance abuse. Neuroscience & Biobehavioral Reviews 33(4):516–524, 2009.
6. Robertson, E.B.; David, S.L.; and Rao, S.A. Preventing Drug Use among Children and Adolescents: A Research-Based Guide for
Parents, Educators, and Community Leaders, 2nd ed. NIH Pub. No. 04-4212(A). Bethesda, MD: National Institute on Drug Abuse,
2003. Available at: http://www.drugabuse.gov/pdf/prevention/RedBook.pdf
7. Dennis, M.; Babor, T.F.; Roebuck, C.; and Donaldson, J. Changing the focus: The case for recognizing and treating cannabis use
disorders. Addiction 97:(s1):4–15, 2002.
8. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health:
Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2013.
9. McCabe, S.E.; West, B.T.; Morales, M.; Cranford, J.A.; and Boyd, C.J. Does early onset of non-medical use of prescription drugs
predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 102(12):1920–1930, 2007.
10. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health:
Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2013.
11. Meier, M.H.; Caspi, A.; Ambler, A.; Harrington, H.L.; Houts, R.; Keefe, R.S.E.; McDonald, K.; Ward, A.; Poulton, R.; and Moffitt,
T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife Proceedings of the National Academy
of Sciences of the United States of America Oct 2;109(40):E2657–E2664, 2012.
12. Dennis, M.L.; White, M.; and Ives, M.I. Individual characteristics and needs associated with substance misuse of adolescents and
young adults in addiction treatment. In Carl Leukefeld, Tom Gullotta, and Michele Staton Tindall (eds.), Handbook on Adolescent
Substance Abuse Prevention and Treatment: Evidence-Based Practice. New London, CT: Child and Family Agency Press, 2009.
13. Chan, Y.F.; Godley, M.D.; Godley, S.H.; and Dennis, M.L. Utilization of mental health services among adolescents in community-
based substance abuse outpatient clinics. The Journal of Behavioral Health Services & Research, Special Issue 35(1):35–51,
2009.
14. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. Quantity and frequency of
alcohol use among underage drinkers. The NSDUH Report: March 31, 2008. Available at:
http://www.samhsa.gov/data/2k8/underage/underage.htm
15. Breda, C.; and Heflinger, C.A. Predicting incentives to change among adolescents with substance abuse disorder. The American
Journal of Drug and Alcohol Abuse 30(2):251–267, 2004.
16. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health:
Summary of National Findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and
Mental Health Services Administration, 2013.
17. National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction. NIH Pub. No. 10-5605, Revised August
2010. Available at: http://www.drugabuse.gov/publications/science-addiction
18. American Society of Addiction Medicine. ASAM Patient Placement Criteria for the Treatment of Substance Related Disorders, 2nd
Edition. Chevy Chase, MD: American Society of Addiction Medicine, 2001.
19. Committee on Substance Abuse, American Academy of Pediatrics. Substance use screening, brief intervention, and
referral to treatment for pediatricians. Pediatrics 128;e1330; 2011. Available at: http://pediatrics.aappublications.org/content/
early/2011/10/26/peds.2011-1754.full.pdf
21. Committee on Substance Abuse, American Academy of Pediatrics. Substance use screening, brief intervention, and
referral to treatment for pediatricians. Pediatrics 128;e1330, 2011. Available at: http://pediatrics.aappublications.org/content/
early/2011/10/26/peds.2011-1754.full.pdf
22. Miller, N.S.; and Flaherty, J.A. Effectiveness of coerced addiction treatment (alternative consequences): A review of the clinical
research. Journal of Substance Abuse Treatment 18(1):9–16, 2000.
23. Chan, Y.F.; Dennis, M.L.; and Funk, R.R. Prevalence and comorbidity co-occurrence of major internalizing and externalizing
disorders among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment
34:14–24, 2008
24. Simpson, T.L.; and Miller, W.R. Concomitance between childhood sexual and physical abuse and substance use problems: A
review. Clinical Psychology Review 22(1):27–77, 2002.
25. Hser, Y.; Grella, C.E.; Hubbard, R.L.; Hsieh, S.C.; Fletcher, B.W.; Brown, B.S.; and Anglin, M.D. An evaluation of drug treatments
for adolescents in 4 US cities. Archives of General Psychiatry 58(7):689–695, 2001.
26. Godley, M.D.; Godley, S.H.; Dennis, M.L.; Funk, R.R.; and Passetti, L.L. The effect of continuing care on continuing care linkage,
adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction 102(1), 2006.
27. Godley, M.D.; Godley, S.H.; Dennis, M.L.; Funk, R.R.; and Passetti, L.L. The effect of assertive continuing care on continuing
care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction
102(1):81–93, 2007.
28. Lambert, E.Y.; Normand, JL.; and Volkow, N.D. Prevention and treatment of HIV/AIDS among drug-using populations: A global
perspective. Journal of Acquired Immune Deficiency Syndromes 55(Suppl 1):S1–S4, 2010.
29. Hagan, H.; Pouget, E.R.; and Des Jarlais, D.C. A systematic review and meta-analysis of interventions to prevent hepatitis C
virus infection in people who inject drugs. Journal of Infectious Diseases 204(1):74–83, 2011.
30. Shane, P.; Diamond, G.S.; Mensinger, J.L.; Shera, D.; and Wintersteen, M.B. Impact of victimization on substance abuse
treatment outcomes for adolescents in outpatient and residential substance abuse treatment. The American Journal on
Addictions 15, Issue Supplement s1:s34–s42, 2010.
31. Nash, S.G.; McQueen, A.; and Bray, J.H. Pathways to adolescent alcohol use: Family environment, peer influence, and parental
expectations. Journal of Adolescent Health 37(1):19–28, 2005.
32. Hall, W.; and Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 374:1383–1391, 2009.
33. Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; and Schulenberg, J.E. Monitoring the Future National Results on Adolescent
Drug Use: Overview of Key Findings, 2013. Bethesda, MD: National Institute on Drug Abuse, 2013. Available at
www.monitoringthefuture.org
34. Storra, C.L.; Westergaard, R.; and Anthony, J.C. Early onset inhalant use and risk for opiate initiation by young adulthood. Drug
and Alcohol Dependence 78(3): 253–261, 2005
35. Pollini, R.A.; Banta-Green, C.J.; Cuevas-Mota, J.; Metzner, M.; Teshale, E.; and Garfein, R.S. Problematic use of prescription-
type opioids prior to heroin use among young heroin injectors. Substance Abuse and Rehabilitation 2:173–180, 2011.
36. Ilieva, I.; Boland, J.; and Farah, M.J. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy
people. Neuropharmacology 64:496–505, 2013.
37. Kanayama, G.; Brower, K.J.; Wood, R.I.; Hudson, J.I.; and Pope, H.G., Jr. Treatment of anabolic-androgenic steroid dependence:
Emerging evidence and its implications. Drug and Alcohol Dependence 109(1-3): 6–13, 2010.
38. Skarberg, K.; Nyberg, F.; and Engstrom, I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids.
European Addiction Research 15(2):99–106, 2009.
39. Humphreys K.L.; Eng, T; and Lee, S.S. Stimulant medication and substance use outcomes: A meta-analysis. JAMA Psychiatry
1–9, 2013.
69. Marsch, L.A. Treatment of adolescents. In Strain, E.C.; and Stitzer, M.L. (eds.) The Treatment of Opioid Dependence. Baltimore,
MD: Johns Hopkins University Press, pp. 497–507, 2005.
70. Fishman, M.J.; Winstanley, E.L.; Curran, E.; Garrett, S.; and Subramaniam, G. Treatment of opioid dependence in adolescents
and young adults with extended release naltrexone: Preliminary case-series and feasibility. Addiction 105(9):1669–1676, 2010.
71. Niederhofer, H.; and Staffen, W. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug
and Alcohol Review 22(3):295–297, 2003.
72. Gray, K.M.; Carpenter, M.J.; Baker, N.L.; Hartwell, K.J.; Lewis, A.L.; Hiott, D.W.; Deas, D.; and Upadhyaya, H.P. Bupropion SR
and contingency management for adolescent smoking cessation. Journal of Substance Abuse Treatment 40(1):77–86, 2011.
73. Moolchan, E.T.; Robinson, M.L.; Ernst, M.; Cadet, J.L.; Pickworth, W.B.; Heishman, S.J.; and Schroeder, J.R. Safety and efficacy
of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 115(4):e407–414, 2005.
74. Gray, K.M.; Carpenter, M.J.; Lewis, A.L.; Klintworth, E.M.; and Upadhyaya, H.P. Varenicline versus bupropion XL for smoking
cessation in older adolescents: A randomized, double-blind pilot trial. Nicotine and Tobacco Research 14(2):234–239, 2012.
75. Godley, M.D.; Godley, S.H.; Dennis, M.L.; Funk, R.R.; and Passetti, L.L. The effect of assertive continuing care on continuing
care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction
102(1):81–93, 2007.
76. Kelly, J.F.; Dow, S.J.; Yeterian, J.D.; and Kahler, C.W. Can 12-step group participation strengthen and extend the benefits of
adolescent addiction treatment? A prospective analysis. Drug and Alcohol Dependence, 110(1-2):117–125, 2010.
77. Substance Abuse and Mental Health Services Administration. What are peer recovery support services? Rockville, MD:
Substance Abuse and Mental Health Services Administration, 2009. Available at: http://store.samhsa.gov/shin/content/SMA09-
4454/SMA09-4454.pdf
78. Moberg, D.P.; and Finch, A.J. Recovery high schools: A descriptive study of school programs and students. Journal of Groups in
Addiction & Recovery 2:128–161, 2008.